Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society

被引:0
|
作者
Rodacki, Melanie [1 ]
Zajdenverg, Lenita [1 ]
da Silva Jr, Wellington Santana [2 ]
Giacaglia, Luciano [3 ]
Negrato, Carlos Antonio [4 ]
Cobas, Roberta Arnoldi [5 ]
de Almeida-Pititto, Bianca [6 ]
Bertoluci, Marcello Casaccia [7 ]
机构
[1] Univ Fed Rio De Janeiro, Dept Clin Med Nutrol, Rio De Janeiro, Brazil
[2] Univ Fed Maranhao, Dept Med 1, Disciplina Endocrinol, Sao Luis, Brazil
[3] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil
[4] Univ Sao Paulo, Fac Med Bauru, Bauru, Brazil
[5] Univ Estado Rio De Janeiro, Fac Ciencias Med, Dept Med Interna, Rio De Janeiro, Brazil
[6] Univ Fed Sao Paulo, Dept Med Prevent, Escola Paulista Med, Sao Paulo, Brazil
[7] Univ Fed Rio Grande do Sul, Serv Endocrinol Hosp Clin Porto Alegre, Fac Med, Porto Alegre, Brazil
来源
DIABETOLOGY & METABOLIC SYNDROME | 2025年 / 17卷 / 01期
关键词
Practice guidelines: type 2 diabetes mellitus; Prediabetic state; Blood glucose; Glycated hemoglobin; Oral glucose tolerance test; Diagnosis; Early diagnosis; Disease prevention; FASTING PLASMA-GLUCOSE; GLYCATED HEMOGLOBIN; CARDIOVASCULAR RISK; METABOLIC SYNDROME; OBESE CHILDREN; TOLERANCE TEST; LIFE-STYLE; FOLLOW-UP; OGTT; PREVALENCE;
D O I
10.1186/s13098-024-01572-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with type 2 diabetes (T2D) often experience prolonged periods of asymptomatic hyperglycemia, which significantly increases the risk of developing chronic complications related to diabetes. Screening programs for individuals at high risk for T2D provide valuable opportunities not only for early diagnosis but also for detecting intermediate hyperglycemic states, commonly referred to as prediabetes. Interventions aimed at preventing diabetes in this group can successfully delay or even avoid the onset of the disease and its associated burdens. This review is an update of the Brazilian Diabetes Society (Sociedade Brasileira de Diabetes [SBD]) evidence-based guideline for diagnosing diabetes and screening T2D. Methods The methodology was previously published and defined by the internal institutional steering committee. The working group drafted the manuscript by selecting vital clinical questions for a narrative review, utilizing MEDLINE via PubMed to identify relevant studies. The review assessed the best available evidence, including randomized clinical trials (RCTs), meta-analyses, and high-quality observational studies related to the diagnosis of diabetes. Results and conclusions Fifteen specific recommendations were formulated. Screening is recommended for adults aged 35 and older or younger individuals with obesity and additional risk factors. For children and adolescents, screening is recommended starting at age ten or the onset of puberty if they are overweight or obese and have additional risk factors. Fasting plasma glucose (FPG) and HbA1c are recommended as initial screening tests. The oral glucose tolerance test (OGTT) is recommended for high-risk individuals with normal HbA1c and FPG or those with prediabetes. The 1-h OGTT is preferred over the 2-h OGTT, as it is both more practical and a superior test. A structured approach to reevaluation intervals is provided.
引用
收藏
页数:18
相关论文
共 50 条
  • [42] 21st Brazilian Diabetes Society Congress
    Diabetology & Metabolic Syndrome, 10 (Suppl 1):
  • [43] 22nd Brazilian Diabetes Society Congress
    不详
    DIABETOLOGY & METABOLIC SYNDROME, 2019, 11 (Suppl 1):
  • [44] A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes
    Bouchi, Ryotaro
    Kondo, Tatsuya
    Ohta, Yasuharu
    Goto, Atsushi
    Tanaka, Daisuke
    Satoh, Hiroaki
    Yabe, Daisuke
    Nishimura, Rimei
    Harada, Norio
    Kamiya, Hideki
    Suzuki, Ryo
    Yamauchi, Toshimasa
    DIABETOLOGY INTERNATIONAL, 2023, 14 (01) : 1 - 14
  • [45] A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes
    Ryotaro Bouchi
    Tatsuya Kondo
    Yasuharu Ohta
    Atsushi Goto
    Daisuke Tanaka
    Hiroaki Satoh
    Daisuke Yabe
    Rimei Nishimura
    Norio Harada
    Hideki Kamiya
    Ryo Suzuki
    Toshimasa Yamauchi
    Diabetology International, 2023, 14 : 1 - 14
  • [46] Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)
    Benetti-Pinto, Cristina Laguna
    Nacul, Andrea Prestes
    Rosa-e-Silva, Ana Carolina Japur de Sa
    Maciel, Gustavo Arantes Rosa
    Nogueira, Vania dos Santos Nunes
    Elias, Paula Conde Lamparelli
    Martins, Manoel
    Kasuki, Leandro
    Garmes, Heraldo Mendes
    Glezer, Andrea
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2024, 68
  • [47] Brazilian Society for Food and Nutrition position statement: gluten-free diet
    Pantaleão L.C.
    Rogero M.M.
    Amancio O.M.S.
    Nutrire, 41 (1)
  • [48] Diabetes Canada Position Statement on Recreational Cannabis Use in Adults and Adolescents With Type 1 and Type 2 Diabetes
    Bajaj, Harpreet S.
    Barnes, Tracy
    Nagpal, Seema
    Tricco, Andrea C.
    Rios, Patricia
    Porr, Caroline
    Senior, Peter
    Huot, Celine
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (06) : 372 - 376
  • [49] Psychometric Performance of the Brazilian Version of the Diabetes Distress Scale in Patients With Diabetes Mellitus Type 2
    Apolinario, Priscila Peruzzo
    Trevisan, Danilo Donizetti
    Matheus Rodrigues, Roberta Cunha
    Jannuzzi, Fernanda Freire
    Ferreira, Julia Fazzio
    de Oliveira, Henrique Ceretta
    Araujo, Eliana Pereira
    de Melo Lima, Maria Helena
    JOURNAL OF NURSING MEASUREMENT, 2016, 24 (02) : E101 - E113
  • [50] Clinical screening for GCK-MODY in 2,989 patients from the Brazilian Monogenic Diabetes Study Group (BRASMOD) and the Brazilian Type 1 Diabetes Study Group (BrazDiab1SG)
    Peixoto-Barbosa, Renata
    Calliari, Luis Eduardo
    Crispim, Felipe
    Moises, Regina S.
    Dib, Sergio A.
    Reis, Andre F.
    Giuffrida, Fernando M. A.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2024, 68